Fred Alger Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.43M Sell
15,672
-394
-2% -$86.2K 0.02% 278
2025
Q1
$3.6M Sell
16,066
-2,556
-14% -$572K 0.02% 256
2024
Q4
$6.1M Buy
18,622
+4,528
+32% +$1.48M 0.03% 222
2024
Q3
$4.23M Sell
14,094
-524
-4% -$157K 0.02% 256
2024
Q2
$4.82M Sell
14,618
-37,150
-72% -$12.2M 0.02% 249
2024
Q1
$20.5M Buy
51,768
+7,580
+17% +$3M 0.1% 146
2023
Q4
$15.6M Sell
44,188
-54,613
-55% -$19.2M 0.08% 156
2023
Q3
$37.1M Buy
98,801
+761
+0.8% +$286K 0.21% 103
2023
Q2
$37.5M Buy
98,040
+28,884
+42% +$11M 0.19% 124
2023
Q1
$24M Buy
69,156
+53,583
+344% +$18.6M 0.13% 154
2022
Q4
$3.67M Sell
15,573
-11,143
-42% -$2.62M 0.02% 287
2022
Q3
$6.57M Buy
26,716
+9,378
+54% +$2.31M 0.03% 234
2022
Q2
$5.24M Buy
17,338
+13,829
+394% +$4.18M 0.02% 262
2022
Q1
$1.44M Sell
3,509
-22,527
-87% -$9.25M ﹤0.01% 359
2021
Q4
$12.2M Buy
26,036
+16,875
+184% +$7.91M 0.03% 231
2021
Q3
$3.89M Hold
9,161
0.01% 304
2021
Q2
$3.29M Sell
9,161
-604
-6% -$217K 0.01% 325
2021
Q1
$2.75M Sell
9,765
-343
-3% -$96.7K 0.01% 330
2020
Q4
$2.86M Sell
10,108
-6
-0.1% -$1.7K 0.01% 311
2020
Q3
$2.78M Buy
10,114
+3,114
+44% +$856K 0.01% 282
2020
Q2
$1.59M Buy
7,000
+6,884
+5,934% +$1.56M 0.01% 321
2020
Q1
$18K Hold
116
﹤0.01% 444
2019
Q4
$17K Buy
+116
New +$17K ﹤0.01% 459
2019
Q1
Sell
-119
Closed -$12K 572
2018
Q4
$12K Hold
119
﹤0.01% 477
2018
Q3
$15K Buy
+119
New +$15K ﹤0.01% 486
2017
Q4
Sell
-9,000
Closed -$866K 596
2017
Q3
$866K Sell
9,000
-4,000
-31% -$385K ﹤0.01% 331
2017
Q2
$1.23M Buy
13,000
+6,000
+86% +$567K 0.01% 322
2017
Q1
$571K Sell
7,000
-1,250
-15% -$102K ﹤0.01% 355
2016
Q4
$700K Buy
8,250
+250
+3% +$21.2K ﹤0.01% 312
2016
Q3
$596K Sell
8,000
-4,000
-33% -$298K ﹤0.01% 344
2016
Q2
$911K Buy
12,000
+1,900
+19% +$144K ﹤0.01% 338
2016
Q1
$700K Buy
+10,100
New +$700K ﹤0.01% 397